5MILLER A B, HOOGSTRATEN B, STAQUET M, et al. Reporting results of cancer treatment [J].Cancer, 1981,47 (1), 207-214. 被引量：1
6DISPENZIERI A C. Chemotherapy induced insulin-dependent diabetes mellitus[J].Journal o{ Clininal Oncology, 1997,15 (3) :1287. 被引量：1
7FALKSON G, GELMAN R S, PANDYA K J, et al. Eastern cooperative oncology group randomized trials of observation versus maintenance therapy for patients with metastatic breast cancer in complete remission following induction treatment [J]. Journal of Clinical Oncology: Official Journal of the A- merican Society of Clinical Oncology, 1998,16(5) :1669-1676. 被引量：1
9NAN D N, FERNNDEZ-AYALA M, VEGA VILLEGAS M E, et al. Diabetes mellitus following cisplatin treatmentEJ~. Acta Oncologica (Stockholm, Sweden), 2003,42 ( 1 ) : 75-78. 被引量：1
7Ferlay J, Shin HR, Bray F, et al. Estimates of world- wide burden of cancer in 2008: GLOBOCAN 2008 [J]. Int J Cancer, 2010, 127 (12) : 2893 -2917. 被引量：1
8Nagel JM, Mansmann U, Wegscheider K, et al. In- sulin resistance and increased risk for malignant neo- plasms: confounding of the data on insulin glargine [J]. Diabetologia, 2010, 53 (1): 206-208. 被引量：1
9Hsing AW, Gao YT, Jr CS, et al. Insulin resistance and prostate cancer risk [ J ]. J Natl Cancer Inst, 2003, 95 (1): 67-71. 被引量：1
10Leroy X, Aubert S, Ballereau C, et al. Diffuse ex- pression of MUC1 in metastases of renal clear cell carci- noma as a possible therapeutic target for renal cancer [J]. Histopathology, 2005, 47 (4): 435-436. 被引量：1
